Mishra J., Dent C., Tarabishi R., et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005, 365:1231-1238.
Nickolas T.L., O'Rourke M.J., Yang J., et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 2008, 148:810-819.
Ricos C., Alvarez V., Cava F., et al. Current databases on biological variation: Pros, cons and progress. Scand J Clin Lab Invest 1999, 59:491-500.
Cavalier E, Bekaert AC, Carlisi A, Legrand D, Krzesinski JM, Delanaye P. NGAL determined in urine with Abbott Architect or in plasma with Biosite Triage? The laboratory's point of view. Clin Chem Lab Med 2011;49(2) [Electronic publication ahead of print]. doi:10.1515/CCLM.2011.044.
Fraser C.G., Harris E.K. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989, 27:409-437.
Waikar S.S., Sabbisetti V.S., Bonventre J.V. Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate. Kidney Int 2010, 78:486-494.
Grenier F.C., Ali S., Syed H., et al. Evaluation of the ARCHITECT urine NGAL assay: Assay performance, specimen handling requirements and biological variability. Clin Biochem 2010, 43:615-620.